E2Open Parent Hldg (ETWO)

$3.24 +0.01 (0.31%)
Market Cap 1.11B
Revenue (ttm) 607.69M
Net Income (ttm) -659.83M
EPS (ttm) N/A
PE Ratio 16.20
Forward PE 17.05
Profit Margin -108.58%
Debt to Equity Ratio 1.18
Volume 1,548,300
Avg Vol 8,276,602
Day's Range N/A - N/A
Shares Out 343.99M
Stochastic %K 100%
Beta 1.27
Analysts Hold
Price Target $2.48

Company Profile

E2open Parent Holdings, Inc. provides cloud-based and end-to-end supply chain management and orchestration SaaS platform in the Americas, Europe, and the Asia Pacific. Its SaaS platform includes various key strategic and operational areas, including omni-channel, demand sensing, supply planning, global trade management, transportation and logistics, and manufacturing and supply management. The company's software combines networks, data, and applications to provide a deeply embedded and mission-c...

Industry: Software - Application
Sector: Technology
Phone: 866 432 6736
Fax: 215 425 3595
Address:
14135 Midway Road, Suite G300, Addison, United States
Winning_calls
Winning_calls Jun. 2 at 3:42 AM
$ETWO pick me up @ $3.23
0 · Reply
Natas6166
Natas6166 May. 28 at 10:55 PM
$ETWO https://www.marketscreener.com/quote/stock/SYNERGY-CHC-CORP-120795410/news/Undervalued-Titans-SNYR-SBET-ETWO-HOLO-Among-High-Growth-Potential-Stocks-Under-10-50085806/
0 · Reply
JarvisFlow
JarvisFlow May. 28 at 4:14 PM
Morgan Stanley has adjusted their stance on E2open Parent Holdings ( $ETWO ), setting the rating to Equal-Weight with a target price of 2.1 → 3.3.
0 · Reply
TheRealShortSqueezy
TheRealShortSqueezy May. 28 at 12:16 PM
💎💎💎UNDERVALUED GEM ALERT 💎💎💎 🧪 $QNTM (Quantum Biopharma) is Canadian biopharmaceutical company which focuses on developing innovative treatments for neurodegenerative, inflammatory, and metabolic disorders, as well as alcohol misuse. 📰On May 20th, they announced their newly signed agreement to prepare a new investigational drug (IND). A successful IND application will allow Quantum Biopharma to move forward with a Phase 2 trial of Lucid-21-302 in people with multiple sclerosis (MS). 🆙From a technical perspective, the share price is on a solid uptrend since beginning of March and with their current pipeline, I wouldn't be surprised to see it grow exponentially in the next few months. 📈Here are my levels: 10.79$➡ 11.62$ ➡ 12.45$ ➡ 13.60$ ➡ 14.52$ ➡ 18$++++ Website : quantumbiopharma.com Disclaimer: tinyurl.com/5b96d3pd $WORX $SBET $EJH $ETWO
0 · Reply
AnalyticaInvestor
AnalyticaInvestor May. 28 at 11:45 AM
$LVWR $RCKT $ETWO $ADTN $LAZR 🔔 Analytica Alpha is live. Small-caps are stirring. $LVWR surged on EV buzz, $RCKT cratered post-trial update, and $ETWO caught fire on acquisition chatter. No hype. Just real moves. 📈 Full breakdown here 👇 #SmallCaps #LVWR #RCKT #ETWO #AnalyticaAlpha https://analyticainvestor.beehiiv.com/p/small-cap-shakeup-one-soared-153-another-crashed-63-f69b3fda453a5763
0 · Reply
jdlman
jdlman May. 28 at 11:36 AM
$ETWO goin in on the dip
0 · Reply
DaBullRunner
DaBullRunner May. 27 at 7:06 PM
$WORX break .70 and this could get interesting $LGPS I’m telling you they are quietly adding for the big reversal There’s a reason why over 71% or insiders own this Also, the CTB is over 100% All this could lead to the perfect storm of a squeeze🍋💦💦💦💦💦 $LVWR $FAAS $ETWO let’s get it
2 · Reply
TheRealShortSqueezy
TheRealShortSqueezy May. 27 at 2:57 PM
🚨🚨🚨🚨New ticker alert 🚨🚨🚨🚨 $RNTX Rein Therapeutics Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas which specializes in developing first-in-class medicines targeting orphan pulmonary and fibrosis indications. ✅ Zero debt ✅ Over $57.6M in assets, only ~$7.7M in liabilities ✅ ~$45M market cap ✅ Bullish analyst coverage with a $7 PT (255%+ upside) 📰News this morning!! Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF Rein Therapeutics pipeline: 🧪LTI-03: Currently in Phase 2 for idiopathic pulmonary fibrosis (IPF). 🧪LTI-01: Completed Phase 2a for loculated pleural effusion (LPE) 🧪LTI-05: In preclinical development for cystic fibrosis. With strategic tech partnerships and a science-driven roadmap, Rein Therapeutics may be one catalyst away from breakout territory. Website: https://www.reintx.com/ Disclaimer: https://tinyurl.com/mu9hsj3v $WORX $SBET $EJH $ETWO
1 · Reply
topstockalerts
topstockalerts May. 27 at 2:13 PM
Morning Top Gainers PT2 $ARQQ $ZENA $ETWO $GYRE $CETX
0 · Reply
topstockalerts
topstockalerts May. 27 at 1:06 PM
Pre Market Top Gainers $SBET $WORX $FAAS $DEVS $ETWO
0 · Reply
Latest News on ETWO
E2open to Report Fiscal 2026 First Quarter Results

Jun 17, 2025, 4:17 PM EDT - 8 days ago

E2open to Report Fiscal 2026 First Quarter Results

Johnson Fistel Investigates Fairness of Proposed Sale of E2open

May 27, 2025, 8:33 AM EDT - 4 weeks ago

Johnson Fistel Investigates Fairness of Proposed Sale of E2open

WiseTech Accelerates Strategy With $2.1 Billion Move for e2open

May 25, 2025, 9:59 PM EDT - 4 weeks ago

WiseTech Accelerates Strategy With $2.1 Billion Move for e2open

Australia's WiseTech to takeover US cloud firm E2open for $2.1 billion

May 25, 2025, 7:04 PM EDT - 4 weeks ago

Australia's WiseTech to takeover US cloud firm E2open for $2.1 billion

E2open Announces Acquisition by WiseTech Global, Concluding Strategic Review

May 25, 2025, 6:44 PM EDT - 4 weeks ago

E2open Announces Acquisition by WiseTech Global, Concluding Strategic Review

E2open Parent Holdings: A Bargain $2 Stock To Consider

May 12, 2025, 2:33 PM EDT - 6 weeks ago

E2open Parent Holdings: A Bargain $2 Stock To Consider

Australia's WiseTech discloses role in US cloud firm E2open's strategic review

May 1, 2025, 5:35 AM EDT - 7 weeks ago

Australia's WiseTech discloses role in US cloud firm E2open's strategic review

E2open Parent Holdings, Inc. (ETWO) Q4 2025 Earnings Call Transcript

Apr 29, 2025, 8:29 PM EDT - 2 months ago

E2open Parent Holdings, Inc. (ETWO) Q4 2025 Earnings Call Transcript

E2open Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results

Apr 29, 2025, 4:17 PM EDT - 2 months ago

E2open Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results

Nutrabolt Selects e2open as Strategic Partner for Digital Supply Chain Transformation

Apr 28, 2025, 9:15 AM EDT - 2 months ago

Nutrabolt Selects e2open as Strategic Partner for Digital Supply Chain Transformation

E2open Named a Leader in Gartner® Magic Quadrant™ for Transportation Management Systems for Third Consecutive Year

Mar 27, 2025, 11:28 AM EDT - 3 months ago

E2open Named a Leader in Gartner® Magic Quadrant™ for Transportation Management Systems for Third Consecutive Year

E2open Introduces Innovations in Global Trade Compliance Technology to Help Companies Address New and Evolving Challenges

Mar 26, 2025, 9:15 AM EDT - 3 months ago

E2open Introduces Innovations in Global Trade Compliance Technology to Help Companies Address New and Evolving Challenges

E2open to Report Fiscal 2025 Fourth Quarter and Full Year Results

Mar 25, 2025, 4:17 PM EDT - 3 months ago

E2open to Report Fiscal 2025 Fourth Quarter and Full Year Results

NYSE to Commence Delisting Proceedings with Respect to Warrants of E2open Parent Holdings, Inc. (ETWO-WT)

Mar 24, 2025, 4:00 PM EDT - 3 months ago

NYSE to Commence Delisting Proceedings with Respect to Warrants of E2open Parent Holdings, Inc. (ETWO-WT)

Batory Foods Improves Demand Distribution, Enhances Service Quality Across Supply Chain Network with e2open Logistics Visibility and Transportation Management

Feb 20, 2025, 9:15 AM EST - 4 months ago

Batory Foods Improves Demand Distribution, Enhances Service Quality Across Supply Chain Network with e2open Logistics Visibility and Transportation Management

E2open Ocean Shipping Index Shows Geopolitical Tensions, Labor Shortages and Port Congestion Driving Significant Increases in Global Transit Times

Jan 31, 2025, 7:15 AM EST - 5 months ago

E2open Ocean Shipping Index Shows Geopolitical Tensions, Labor Shortages and Port Congestion Driving Significant Increases in Global Transit Times

E2open Named a Leader in IDC MarketScape for Worldwide SaaS and Cloud-Enabled Direct Spend

Jan 23, 2025, 9:15 AM EST - 5 months ago

E2open Named a Leader in IDC MarketScape for Worldwide SaaS and Cloud-Enabled Direct Spend

E2open Names Susan Bennett as Chief Legal Officer and Secretary

Jan 21, 2025, 9:15 AM EST - 5 months ago

E2open Names Susan Bennett as Chief Legal Officer and Secretary

Ratings Downgrade For E2open: Earnings Miss And Growth Concerns Persist

Jan 15, 2025, 5:14 AM EST - 5 months ago

Ratings Downgrade For E2open: Earnings Miss And Growth Concerns Persist

E2open Parent Holdings: Positive On Retention Gains And Mid-Market Opportunities

Jan 14, 2025, 8:02 AM EST - 5 months ago

E2open Parent Holdings: Positive On Retention Gains And Mid-Market Opportunities

E2open Parent Holdings, Inc. (ETWO) Q3 2025 Earnings Call Transcript

Jan 10, 2025, 11:21 AM EST - 5 months ago

E2open Parent Holdings, Inc. (ETWO) Q3 2025 Earnings Call Transcript

E2open Announces Fiscal 2025 Third Quarter Financial Results

Jan 10, 2025, 7:45 AM EST - 5 months ago

E2open Announces Fiscal 2025 Third Quarter Financial Results

E2open Named a Leader in Multiple IDC MarketScapes for Worldwide Supply Chain Planning

Jan 7, 2025, 9:15 AM EST - 6 months ago

E2open Named a Leader in Multiple IDC MarketScapes for Worldwide Supply Chain Planning

E2open Reschedules Reporting of Fiscal Third Quarter 2025 Results in Observance of the National Day of Mourning of Former President Jimmy Carter

Jan 3, 2025, 4:15 PM EST - 6 months ago

E2open Reschedules Reporting of Fiscal Third Quarter 2025 Results in Observance of the National Day of Mourning of Former President Jimmy Carter

E2open Names Pawan Joshi as Chief Strategy Officer, Welcomes Rachit Lohani as Chief Product and Technology Officer

Dec 20, 2024, 9:15 AM EST - 6 months ago

E2open Names Pawan Joshi as Chief Strategy Officer, Welcomes Rachit Lohani as Chief Product and Technology Officer

E2open to Report Fiscal Third Quarter 2025 Results

Dec 12, 2024, 4:17 PM EST - 6 months ago

E2open to Report Fiscal Third Quarter 2025 Results

E2open Faces Organic Growth Challenges, Debt Overhang: Goldman Sachs Downgrades Stock

Dec 11, 2024, 2:52 PM EST - 7 months ago

E2open Faces Organic Growth Challenges, Debt Overhang: Goldman Sachs Downgrades Stock

FREIGHTOS AND E2OPEN COLLABORATE TO SIMPLIFY AIR CARGO BOOKINGS

Nov 21, 2024, 7:00 AM EST - 7 months ago

FREIGHTOS AND E2OPEN COLLABORATE TO SIMPLIFY AIR CARGO BOOKINGS

CRGO

E2open Ocean Shipping Index Cites Ongoing Conflict, Extreme Weather and Threat of Labor Strikes as Key Drivers of Port Congestion and Longer Transit Times

Nov 7, 2024, 9:15 AM EST - 8 months ago

E2open Ocean Shipping Index Cites Ongoing Conflict, Extreme Weather and Threat of Labor Strikes as Key Drivers of Port Congestion and Longer Transit Times

E2open Parent Holdings: Long-Term Growth Outlook Remains Intact

Oct 21, 2024, 11:53 PM EDT - 8 months ago

E2open Parent Holdings: Long-Term Growth Outlook Remains Intact

Earnings In Reverse, But E2open Gears Up For A U-Turn

Oct 15, 2024, 3:37 PM EDT - 9 months ago

Earnings In Reverse, But E2open Gears Up For A U-Turn

E2open Parent Holdings, Inc. (ETWO) Q2 2025 Earnings Call Transcript

Oct 9, 2024, 8:37 PM EDT - 9 months ago

E2open Parent Holdings, Inc. (ETWO) Q2 2025 Earnings Call Transcript

E2open Parent Holdings Inc Reports Q2 FY25 Revenue of $152.

Oct 9, 2024, 4:33 PM EDT - 9 months ago

E2open Parent Holdings Inc Reports Q2 FY25 Revenue of $152.

E2open Announces Fiscal 2025 Second Quarter Financial Results

Oct 9, 2024, 4:17 PM EDT - 9 months ago

E2open Announces Fiscal 2025 Second Quarter Financial Results

E2open Releases 2024 Forecasting and Inventory Benchmark Study: Lessons from the Pandemic for Future Resilience

Oct 2, 2024, 9:15 AM EDT - 9 months ago

E2open Releases 2024 Forecasting and Inventory Benchmark Study: Lessons from the Pandemic for Future Resilience

E2open to Report Fiscal Second Quarter 2025 Results

Sep 13, 2024, 4:17 PM EDT - 10 months ago

E2open to Report Fiscal Second Quarter 2025 Results

E2open Ocean Shipping Index Reveals Sharp Increase in Global Ocean Shipment Transit Times Due to Multiple Ongoing Disruptions

Jul 31, 2024, 9:15 AM EDT - 11 months ago

E2open Ocean Shipping Index Reveals Sharp Increase in Global Ocean Shipment Transit Times Due to Multiple Ongoing Disruptions

E2open Parent Holdings: Buy Rated As Growth Slowdown Was Likely A One-Off Event

Jul 13, 2024, 3:08 AM EDT - 1 year ago

E2open Parent Holdings: Buy Rated As Growth Slowdown Was Likely A One-Off Event

E2open Parent Holdings: Turnaround Stalls In Q1

Jul 11, 2024, 11:23 AM EDT - 1 year ago

E2open Parent Holdings: Turnaround Stalls In Q1

E2open Parent Holdings, Inc. (ETWO) Q1 2025 Earnings Call Transcript

Jul 11, 2024, 3:38 AM EDT - 1 year ago

E2open Parent Holdings, Inc. (ETWO) Q1 2025 Earnings Call Transcript

E2open Announces Fiscal 2025 First Quarter Financial Results

Jul 10, 2024, 4:15 PM EDT - 1 year ago

E2open Announces Fiscal 2025 First Quarter Financial Results

E2open Releases 2024 Sustainability Report

Jul 3, 2024, 9:15 AM EDT - 1 year ago

E2open Releases 2024 Sustainability Report

E2open Introduces Appointment Scheduling API in Transportation Management Solution to Improve Efficiency and Enhance Collaboration Among Supply Chain Partners

Jun 26, 2024, 9:15 AM EDT - 1 year ago

E2open Introduces Appointment Scheduling API in Transportation Management Solution to Improve Efficiency and Enhance Collaboration Among Supply Chain Partners

E2open to Report Fiscal First Quarter 2025 Results

Jun 17, 2024, 4:17 PM EDT - 1 year ago

E2open to Report Fiscal First Quarter 2025 Results

E2open Parent Holdings: Upgrade To Buy On Positive Execution And New Sales Strategy

May 15, 2024, 4:23 PM EDT - 1 year ago

E2open Parent Holdings: Upgrade To Buy On Positive Execution And New Sales Strategy

E2open Announces Connect Europe 2024 Client Award Winners

May 2, 2024, 9:15 AM EDT - 1 year ago

E2open Announces Connect Europe 2024 Client Award Winners

E2open Parent Holdings, Inc. (ETWO) Q4 2024 Earnings Call Transcript

Apr 29, 2024, 10:01 PM EDT - 1 year ago

E2open Parent Holdings, Inc. (ETWO) Q4 2024 Earnings Call Transcript

E2open Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results

Apr 29, 2024, 4:15 PM EDT - 1 year ago

E2open Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results

E2open Achieves Interoperability Certification on the Catena-X Network

Apr 24, 2024, 9:15 AM EDT - 1 year ago

E2open Achieves Interoperability Certification on the Catena-X Network

Winning_calls
Winning_calls Jun. 2 at 3:42 AM
$ETWO pick me up @ $3.23
0 · Reply
Natas6166
Natas6166 May. 28 at 10:55 PM
$ETWO https://www.marketscreener.com/quote/stock/SYNERGY-CHC-CORP-120795410/news/Undervalued-Titans-SNYR-SBET-ETWO-HOLO-Among-High-Growth-Potential-Stocks-Under-10-50085806/
0 · Reply
JarvisFlow
JarvisFlow May. 28 at 4:14 PM
Morgan Stanley has adjusted their stance on E2open Parent Holdings ( $ETWO ), setting the rating to Equal-Weight with a target price of 2.1 → 3.3.
0 · Reply
TheRealShortSqueezy
TheRealShortSqueezy May. 28 at 12:16 PM
💎💎💎UNDERVALUED GEM ALERT 💎💎💎 🧪 $QNTM (Quantum Biopharma) is Canadian biopharmaceutical company which focuses on developing innovative treatments for neurodegenerative, inflammatory, and metabolic disorders, as well as alcohol misuse. 📰On May 20th, they announced their newly signed agreement to prepare a new investigational drug (IND). A successful IND application will allow Quantum Biopharma to move forward with a Phase 2 trial of Lucid-21-302 in people with multiple sclerosis (MS). 🆙From a technical perspective, the share price is on a solid uptrend since beginning of March and with their current pipeline, I wouldn't be surprised to see it grow exponentially in the next few months. 📈Here are my levels: 10.79$➡ 11.62$ ➡ 12.45$ ➡ 13.60$ ➡ 14.52$ ➡ 18$++++ Website : quantumbiopharma.com Disclaimer: tinyurl.com/5b96d3pd $WORX $SBET $EJH $ETWO
0 · Reply
AnalyticaInvestor
AnalyticaInvestor May. 28 at 11:45 AM
$LVWR $RCKT $ETWO $ADTN $LAZR 🔔 Analytica Alpha is live. Small-caps are stirring. $LVWR surged on EV buzz, $RCKT cratered post-trial update, and $ETWO caught fire on acquisition chatter. No hype. Just real moves. 📈 Full breakdown here 👇 #SmallCaps #LVWR #RCKT #ETWO #AnalyticaAlpha https://analyticainvestor.beehiiv.com/p/small-cap-shakeup-one-soared-153-another-crashed-63-f69b3fda453a5763
0 · Reply
jdlman
jdlman May. 28 at 11:36 AM
$ETWO goin in on the dip
0 · Reply
DaBullRunner
DaBullRunner May. 27 at 7:06 PM
$WORX break .70 and this could get interesting $LGPS I’m telling you they are quietly adding for the big reversal There’s a reason why over 71% or insiders own this Also, the CTB is over 100% All this could lead to the perfect storm of a squeeze🍋💦💦💦💦💦 $LVWR $FAAS $ETWO let’s get it
2 · Reply
TheRealShortSqueezy
TheRealShortSqueezy May. 27 at 2:57 PM
🚨🚨🚨🚨New ticker alert 🚨🚨🚨🚨 $RNTX Rein Therapeutics Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas which specializes in developing first-in-class medicines targeting orphan pulmonary and fibrosis indications. ✅ Zero debt ✅ Over $57.6M in assets, only ~$7.7M in liabilities ✅ ~$45M market cap ✅ Bullish analyst coverage with a $7 PT (255%+ upside) 📰News this morning!! Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF Rein Therapeutics pipeline: 🧪LTI-03: Currently in Phase 2 for idiopathic pulmonary fibrosis (IPF). 🧪LTI-01: Completed Phase 2a for loculated pleural effusion (LPE) 🧪LTI-05: In preclinical development for cystic fibrosis. With strategic tech partnerships and a science-driven roadmap, Rein Therapeutics may be one catalyst away from breakout territory. Website: https://www.reintx.com/ Disclaimer: https://tinyurl.com/mu9hsj3v $WORX $SBET $EJH $ETWO
1 · Reply
topstockalerts
topstockalerts May. 27 at 2:13 PM
Morning Top Gainers PT2 $ARQQ $ZENA $ETWO $GYRE $CETX
0 · Reply
topstockalerts
topstockalerts May. 27 at 1:06 PM
Pre Market Top Gainers $SBET $WORX $FAAS $DEVS $ETWO
0 · Reply
Ric_1M
Ric_1M May. 27 at 1:03 PM
$SBET $WORX $FAAS $DEVS $ETWO "Maybe, just maybe, life isn't good or bad, it just is life. Maybe, just maybe, there are no good or bad stories; simply time will tell." Yokoi Kenji Díaz
0 · Reply
OpenOutcrier
OpenOutcrier May. 27 at 12:54 PM
$ETWO (+26.5% pre) E2open to be acquired by WiseTech Global for $3.30 per share in cash https://ooc.bz/l/65917
0 · Reply
StockElementCorporation
StockElementCorporation May. 27 at 12:36 PM
Premarket movers 📈 $SBET +280% $WORX +90% $EJH +27% $ETWO +26% $HOLO +17.8% DJT +9.8% JFBR +8.4% UEC +8.4% QUBT +5.2% RCKT -63%
0 · Reply
Bullish_Scanner
Bullish_Scanner May. 27 at 12:28 PM
Premarket Gappers $SBET $WORX $FAAS $ETWO $HOLO
0 · Reply
gerbey
gerbey May. 27 at 12:20 PM
Good morning everyone, pre market movers: $SBET 242% $FAAS 93% $WORX 85% $ETWO 26% $EJH 21% Don't forget to follow ! ✅
0 · Reply
briefingcom
briefingcom May. 27 at 12:17 PM
Gapping Up: $ETWO +26.1% $MTAL +19% $ATS +17.4% $DGNX +16.6%
0 · Reply
AlertsAndNews
AlertsAndNews May. 27 at 12:08 PM
Good morning traders, gappers this morning include $SBET $WORX $EJH $ETWO $HOLO Let's get it!
1 · Reply
fzriderz
fzriderz May. 27 at 11:23 AM
$SBET $ETWO 1000% gainer today
0 · Reply
topstockalerts
topstockalerts May. 27 at 11:19 AM
Pre Market Top Gainers $WORX $SBET $EJH $BRNS $ETWO
0 · Reply
AZOZ
AZOZ May. 27 at 10:47 AM
Good morning America 🇺🇸 Small cap premarket movers $HOLO $WORX $SBET $EJH $ETWO
0 · Reply
Shanthi_Rexaline
Shanthi_Rexaline May. 27 at 3:44 AM
Supply Chain SaaS Firm E2open Gets Snapped Up By Australia’s WiseTech In $2B Deal: Retail Mood Stays ‘Neutral’ https://stocktwits.com/news-articles/markets/equity/supply-chain-saas-firm-e2open-gets-snapped-up-by-wisetech/ch0NxP9RbAg $ETWO
0 · Reply
StocktwitsNews
StocktwitsNews May. 27 at 3:43 AM
Supply Chain SaaS Firm E2open Gets Snapped Up By Australia’s WiseTech In $2B Deal: Retail Mood Stays ‘Neutral’ $ETWO $IWM https://stocktwits.com/news/equity/markets/supply-chain-saas-firm-e2open-gets-snapped-up-by-wisetech/ch0NxP9RbAg
0 · Reply